4
Changes in Ownership
Faeth Therapeutics, Inc. Filed Acc 0001567619-22-001464
Director bought 30,244 shares at an average $5.10 ($154,313)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Peyer James Director | 2022-01-19 | Purchase | +10,244 | $4.97 | $50,913 | 4,995,876 | I: show line 1 in the form |
| Peyer James Director | 2022-01-20 | Purchase | +20,000 | $5.17 | $103,400 | 5,015,876 | I: show line 2 in the form |
| Open-market purchases · 30,244 sh · avg $5.10 · $154,313 | |||||||
Loading xslF345X03/doc1.xml…